Sheehan Suicidality Tracking Scale (Sheehan-STS): Preliminary Results from a Multicenter Clinical Trial in Generalized Anxiety Disorder

Por Coric, Vladimir, Stock, Elyse G., Pultz, Joseph, Marcus, Ronald, Sheehan, David V.
Publicado em 2009

The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazo...

Por Hanssens, Linda, L'Italien, Gilbert, Loze, Jean-Yves, Marcus, Ronald N, Pans, Miranda, Kerselaers, Wendy
Publicado em 2008

Aripiprazole Treatment of Irritability Associated with Autistic Disorder and the Relationship Between Prior Antipsychotic Exposure, Adverse Events, and Weight Change

Por Mankoski, Raymond, Stockton, Gwen, Manos, George, Marler, Sabrina, McQuade, Robert, Forbes, Robert A., Marcus, Ronald
Publicado em 2013

Safety and Tolerability of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder in Pediatric Subjects (6–17 Years Old):Results From a Pooled Analysis of...

Por Robb, Adelaide S., Andersson, Candace, Bellocchio, Elizabeth E., Manos, George, Rojas-Fernandez, Carlos, Mathew, Suja, Marcus, Ronald, Owen, Randall, Mankoski, Raymond
Publicado em 2011

Clinical Significance of Treatment Effects with Aripiprazole versus Placebo in a Study of Manic or Mixed Episodes Associated with Pediatric Bipolar I Disorder

Por Youngstrom, Eric, Zhao, Joan, Mankoski, Raymond, Forbes, Robert A., Marcus, Ronald M., Carson, William, McQuade, Robert, Findling, Robert L.
Publicado em 2013

Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning...

Por Clayton, Anita H, Baker, Ross A, Sheehan, John J, Cain, Zachary J, Forbes, Robert A, Marler, Sabrina Vogel, Marcus, Ronald, Berman, Robert M, Thase, Michael E
Publicado em 2014

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder

Por Berman, Robert M, Thase, Michael E, Trivedi, Madhukar H, Hazel, James A, Marler, Sabrina Vogel, McQuade, Robert D, Carson, William, Baker, Ross A, Marcus, Ronald N
Publicado em 2011

Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy

Por Nelson, J. Craig, Rahman, Zia, Laubmeier, Kimberly K., Eudicone, James M., McQuade, Robert D., Berman, Robert M., Marcus, Ronald N., Baker, Ross A., Sheehan, John J.
Publicado no CNS Spectr (2014)

Examining the Efficacy of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Analysis of 2 Studies

Por Thase, Michael E., Trivedi, Madhukar H., Nelson, J. Craig, Fava, Maurizio, Swanink, Rene, Tran, Quynh-Van, Pikalov, Andrei, Yang, Huyuan, Carlson, Berit X., Marcus, Ronald N., Berman, Robert M.
Publicado em 2008

Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163)

Por Nelson, J. Craig, Thase, Michael E., Trivedi, Madhukar H., Fava, Maurizio, Han, Jian, Van Tran, Quynh, Pikalov, Andrei, Qi, Ying, Carlson, Berit X., Marcus, Ronald N., Berman, Robert M.
Publicado em 2009

Changes in Non-high-density Lipoprotein Cholesterol Levels and Triglyceride/High-density Lipoprotein Cholesterol Ratios among Patients Randomized to Aripiprazole versus Olanzapine

Por Newcomer, John W., Meyer, Jonathan M., Baker, Ross A., Eudicone, James M., Pikalov, Andrei, Vester-Blokland, Estelle, McQuade, Robert D., Crandall, David T., Carson, William H., Marcus, Ronald N., L'Italien, Gilbert
Publicado em 2008